6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Glaucoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agarwal, N; Balasubramanian, D; Chalasani, ML; Gupta, V; Radha, V; Swarup, G | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Glaucoma
Article | Year |
---|---|
A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Blotting, Western; Cell Culture Techniques; Cell Cycle Proteins; Cell Survival; Chlorocebus aethiops; Chromans; COS Cells; Fluorescent Antibody Technique, Indirect; Glaucoma; HeLa Cells; Humans; Membrane Transport Proteins; Mutation; Oxidative Stress; Plasmids; Rats; Reactive Oxygen Species; Retinal Ganglion Cells; Transcription Factor TFIIIA; Transfection; Tumor Necrosis Factor-alpha | 2007 |